A historical perspective on bacterial persistence

Methods in Molecular Biology

Volumn 1333, Issue , 2016, Pages 3-13

  Verstraeten, Natalie ^a   Knapen, Wouter ^a   Fauvart, Maarten ^a   Michiels, Jan ^a  

^a NONE

Author keywords

Antibiotic tolerance; Antibiotics; Dormancy; Persistence; Persisters; Review

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; BACTERIAL CELL; BACTERIAL INFECTION; BACTERIAL PERSISTENCE; BACTERIAL SURVIVAL; BACTERICIDAL ACTIVITY; BACTERIUM CULTURE; ESCHERICHIA COLI; NONHUMAN; PSEUDOMONAS AERUGINOSA; RECURRENT DISEASE; DIRECTED MOLECULAR EVOLUTION; DRUG EFFECTS; GENE EXPRESSION PROFILING; GENETICS; HUMAN; INFECTION; MICROBIAL VIABILITY; MICROBIOLOGY; PROCEDURES; SINGLE CELL ANALYSIS;

ANTI-BACTERIAL AGENTS; DIRECTED MOLECULAR EVOLUTION; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; GENE EXPRESSION PROFILING; HUMANS; INFECTION; MICROBIAL VIABILITY; SINGLE-CELL ANALYSIS;

EID: 84945207650     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-2854-5_1     Document Type: Chapter

References (84)

1. Hobby GL, Meyer K, Chaffee E (1942) Observations on the mechanism of action of penicillin. Exp Biol Med 50(2):281-285
2. Bigger JW (1944) Treatment of staphylococcal infections with penicillin. Lancet 244:497-500
3. Lewis K (2010) Persister cells. Annu Rev Microbiol 64:357-372
4. Moyed HS, Bertrand KP (1983) hipA, a newly recognized gene of Escherichia coli K-12 that affects frequency of persistence after inhibition of murein synthesis. J Bacteriol 155 (2):768-775
5. Moyed HS, Broderick SH (1986) Molecular cloning and expression of hipA, a gene of Escherichia coli K-12 that affects frequency of persistence after inhibition of murein synthesis. J Bacteriol 166(2):399-403
6. Keren I, Shah D, Spoering A, Kaldalu N, Lewis K (2004) Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli. J Bacteriol 186(24):8172-8180
7. Correia FF, D’Onofrio A, Rejtar T, Li L, Karger BL, Makarova K, Koonin EV, Lewis K (2006) Kinase activity of overexpressed HipA is required for growth arrest and multidrug tolerance in Escherichia coli. J Bacteriol 188 (24):8360-8367
8. Hansen S, Vulic M, Min J, Yen TJ, Schumacher MA, Brennan RG, Lewis K (2012) Regulation of the Escherichia coli HipBA toxin-antitoxin system by proteolysis. PLoS One 7(6):e39185
9. Kaspy I, Rotem E, Weiss N, Ronin I, Balaban NQ, Glaser G (2013) HipA-mediated antibiotic persistence via phosphorylation of the glutamyl-tRNA-synthetase. Nat Commun 4:3001
10. Germain E, Castro-Roa D, Zenkin N, Gerdes K (2013) Molecular mechanism of bacterial persistence by HipA. Mol Cell 52(2):248-254
11. Balaban NQ, Merrin J, Chait R, Kowalik L, Leibler S (2004) Bacterial persistence as a phenotypic switch. Science 305(5690):1622-1625
12. Yamaguchi Y, Inouye M (2011) Regulation of growth and death in Escherichia coli by toxinantitoxin systems. Nat Rev Microbiol 9(11): 779-790
13. Yamaguchi Y, Park JH, Inouye M (2011) Toxin-antitoxin systems in bacteria and archaea. Annu Rev Genet 45:61-79
14. Williams JJ, Hergenrother PJ (2012) Artificial activation of toxin-antitoxin systems as an antibacterial strategy. Trends Microbiol 20(6): 291-298
15. Kim Y, Wang X, Zhang XS, Grigoriu S, Page R, Peti W, Wood TK (2010) Escherichia coli toxin/antitoxin pair MqsR/MqsA regulate toxin CspD. Environ Microbiol 12(5): 1105-1121
16. Kim Y, Wood TK (2010) Toxins Hha and CspD and small RNA regulator Hfq are involved in persister cell formation through MqsR in Escherichia coli. Biochem Biophys Res Commun 391(1):209-213
17. Cheng HY, Soo VW, Islam S, McAnulty MJ, Benedik MJ, Wood TK (2013) Toxin GhoT of the GhoT/GhoS TA system damages the cell membrane to reduce ATP and to reduce growth under stress. Environ Microbiol 16 (6):1741-1754
18. Dörr T, Lewis K, Vulić M (2009) SOS response induces persistence to fluoroquinolones in Escherichia coli. PLoS Genet 5(12):e1000760
19. Dörr T, Vulić M, Lewis K (2010) Ciprofloxacin causes persister formation by inducing the TisB toxin in Escherichia coli. PLoS Biol 8(2): e1000317
20. Tripathi A, Dewan PC, Siddique SA, Varadarajan R (2014) MazF-induced growth inhibition and persister generation in Escherichia coli. J Biol Chem 289(7):4191-4205
21. Harrison JJ, Wade WD, Akierman S, Vacchi-Suzzi C, Stremick CA, Turner RJ, Ceri H (2009) The chromosomal toxin gene yafQ is a determinant of multidrug tolerance for Escherichia coli growing in a biofilm. Antimicrob Agents Chemother 53(6):2253-2258
22. Helaine S, Cheverton AM, Watson KG, Faure LM, Matthews SA, Holden DW (2014) Internalization of Salmonella by macrophages induces formation of nonreplicating persisters. Science 343(6167):204-208
23. Maisonneuve E, Shakespeare LJ, Jørgensen MG, Gerdes K (2011) Bacterial persistence by RNA endonucleases. Proc Natl Acad Sci U S A 108(32):13206-13211
24. Fauvart M, De Groote VN, Michiels J (2011) Role of persister cells in chronic infections: clinical relevance and perspectives on anti-persister therapies. J Med Microbiol 60(Pt 6): 699-709
25. Lewis K (2001) Riddle of biofilm resistance. Antimicrob Agents Chemother 45(4): 999-1007
26. Spoering AL, Lewis K (2001) Biofilms and planktonic cells of Pseudomonas aeruginosa have similar resistance to killing by antimicrobials. J Bacteriol 183(23):6746-6751
27. Costerton JW, Stewart PS, Greenberg EP (1999) Bacterial biofilms: a common cause of persistent infections. Science 284(5418): 1318-1322
28. Levin BR, Rozen DE (2006) Non-inherited antibiotic resistance. Nat Rev Microbiol 4(7): 556-562
29. LaFleur MD, Qi Q, Lewis K (2010) Patients with long-term oral carriage harbor high-persister mutants of Candida albicans. Antimicrob Agents Chemother 54(1):39-44
30. Mulcahy LR, Burns JL, Lory S, Lewis K (2010) Emergence of Pseudomonas aeruginosa strains producing high levels of persister cells in patients with cystic fibrosis. J Bacteriol 192 (23):6191-6199
31. Cohen NR, Lobritz MA, Collins JJ (2013) Microbial persistence and the road to drug resistance. Cell Host Microbe 13(6):632-642
32. Fu Y, Zhu M, Xing J (2010) Resonant activation: a strategy against bacterial persistence. Phys Biol 7(1):16013
33. Niepa TH, Gilbert JL, Ren D (2012) Controlling Pseudomonas aeruginosa persister cells by weak electrochemical currents and synergistic effects with tobramycin. Biomaterials 33(30):7356-7365
34. Manuel J, Zhanel GG, de Kievit T (2010) Cadaverine suppresses persistence to carboxypenicillins in Pseudomonas aeruginosa PAO1. Antimicrob Agents Chemother 54(12):5173-5179
35. Allison KR, Brynildsen MP, Collins JJ (2011) Metabolite-enabled eradication of bacterial persisters by aminoglycosides. Nature 473 (7346):216-220
36. Barraud N, Buson A, Jarolimek W, Rice SA (2013) Mannitol enhances antibiotic sensitivity of persister bacteria in Pseudomonas aeruginosa biofilms. PLoS One 8(12):e84220
37. Bahar AA, Ren D (2013) Antimicrobial peptides. Pharmaceuticals (Basel) 6(12): 1543-1575
38. Pan J, Bahar AA, Syed H, Ren D (2012) Reverting antibiotic tolerance of Pseudomonas aeruginosa PAO1 persister cells by (Z)-4-bromo-5-(bromomethylene)-3-methylfuran-2(5H)-one. PLoS One 7(9):e45778
39. Pan J, Ren D (2013) Structural effects on persister control by brominated furanones. Bioorg Med Chem Lett 23(24):6559-6562
40. Pan J, Song F, Ren D (2013) Controlling persister cells of Pseudomonas aeruginosa PDO300 by (Z)-4-bromo-5-(bromomethylene)-3-methylfuran-2(5H)-one. Bioorg Med Chem Lett 23(16):4648-4651
41. Pan J, Xie X, Tian W, Bahar AA, Lin N, Song F, An J, Ren D (2013) (Z)-4-bromo-5-(bromomethylene)-3-methylfuran-2(5H)-one sensitizes Escherichia coli persister cells to antibiotics. Appl Microbiol Biotechnol 97 (20):9145-9154
42. Conlon BP, Nakayasu ES, Fleck LE, LaFleur MD, Isabella VM, Coleman K, Leonard SN, Smith RD, Adkins JN, Lewis K (2013) Activated ClpP kills persisters and eradicates a chronic biofilm infection. Nature 503(7476): 365-370
43. Lewis K (2008) Multidrug tolerance of biofilms and persister cells. Curr Top Microbiol Immunol 322:107-131
44. Hansen S, Lewis K, Vulić M (2008) Role of global regulators and nucleotide metabolism in antibiotic tolerance in Escherichia coli. Antimicrob Agents Chemother 52(8):2718-2726
45. De Groote VN, Verstraeten N, Fauvart M, Kint CI, Cornelis P, Michiels J (2009) Identification of novel persistence genes in Pseudomonas aeruginosa in the combat against emerging antimicrobial resistance. Commun Agric Appl Biol Sci 74(4):51-56
46. Spoering AL, Vulić M, Lewis K (2006) GlpD and PlsB participate in persister cell formation in Escherichia coli. J Bacteriol 188(14): 5136-5144
47. Gefen O, Gabay C, Mumcuoglu M, Engel G, Balaban NQ (2008) Single-cell protein induction dynamics reveals a period of vulnerability to antibiotics in persister bacteria. Proc Natl Acad Sci U S A 105(16):6145-6149
48. Vega NM, Allison KR, Khalil AS, Collins JJ (2012) Signaling-mediated bacterial persister formation. Nat Chem Biol 8(5):431-433
49. Maisonneuve E, Castro-Camargo M, Gerdes K (2013) (p)ppGpp controls bacterial persistence by stochastic induction of toxin-antitoxin activity. Cell 154(5):1140-1150
50. Rotem E, Loinger A, Ronin I, Levin-Reisman I, Gabay C, Shoresh N, Biham O, Balaban NQ (2010) Regulation of phenotypic variability by a threshold-based mechanism underlies bacterial persistence. Proc Natl Acad Sci U S A 107 (28):12541-12546
51. Jõers A, Kaldalu N, Tenson T (2010) The frequency of persisters in Escherichia coli reflects the kinetics of wake-up from dormancy. J Bacteriol 192(13):3379-3384
52. Orman MA, Brynildsen MP (2013) Dormancy is not necessary or sufficient for bacterial persistence. Antimicrob Agents Chemother 57 (7):3230-3239
53. Helaine S, Thompson JA, Watson KG, Liu M, Boyle C, Holden DW (2010) Dynamics of intracellular bacterial replication at the single cell level. Proc Natl Acad Sci U S A 107 (8):3746-3751
54. Claudi B, Sprote P, Chirkova A, Personnic N, Zankl J, Schurmann N, Schmidt A, Bumann D (2014) Phenotypic variation of Salmonella in host tissues delays eradication by antimicrobial chemotherapy. Cell 158(4):722-733
55. Keren I, Minami S, Rubin E, Lewis K (2011) Characterization and transcriptome analysis of Mycobacterium tuberculosis persisters. MBio 2 (3):e00100-e00111
56. Shah D, Zhang Z, Khodursky A, Kaldalu N, Kurg K, Lewis K (2006) Persisters: a distinct physiological state of E. coli. BMC Microbiol 6:53
57. Fridman O, Goldberg A, Ronin I, Shoresh N, Balaban NQ (2014) Optimization of lag time underlies antibiotic tolerance in evolved bacterial populations. Nature 513(7518):418-421
58. Levin-Reisman I, Gefen O, Fridman O, Ronin I, Shwa D, Sheftel H, Balaban NQ (2010) Automated imaging with ScanLag reveals previously undetectable bacterial growth phenotypes. Nat Methods 7(9):737-739
59. Kussell E, Kishony R, Balaban NQ, Leibler S (2005) Bacterial persistence: a model of survival in changing environments. Genetics 169 (4):1807-1814
60. Cogan NG (2007) Incorporating toxin hypothesis into a mathematical model of persister formation and dynamics. J Theor Biol 248(2):340-349
61. Gardner A, West SA, Griffin AS (2007) Is bacterial persistence a social trait? PLoS One 2(8): e752
62. Klapper I, Gilbert P, Ayati BP, Dockery J, Stewart PS (2007) Senescence can explain microbial persistence. Microbiology 153(Pt 11): 3623-3630
63. Gefen O, Balaban NQ (2009) The importance of being persistent: heterogeneity of bacterial populations under antibiotic stress. FEMS Microbiol Rev 33(4):704-717
64. Hemsley CM, Luo JX, Andreae CA, Butler CS, Soyer OS, Titball RW (2014) Bacterial drug tolerance under clinical conditions is governed by anaerobic adaptation but not anaerobic respiration. Antimicrob Agents Chemother 58 (10):5775-5783
65. Gelens L, Hill L, Vandervelde A, Danckaert J, Loris R (2013) A general model for toxin-antitoxin module dynamics can explain persister cell formation in E. coli. PLoS Comput Biol 9 (8):e1003190
66. Lou C, Li Z, Ouyang Q (2008) A molecular model for persister in E. coli. J Theor Biol 255 (2):205-209
67. Veening JW, Smits WK, Kuipers OP (2008) Bistability, epigenetics, and bet-hedging in bacteria. Annu Rev Microbiol 62:193-210
68. Nguyen D, Joshi-Datar A, Lepine F, Bauerle E, Olakanmi O, Beer K, McKay G, Siehnel R, Schafhauser J, Wang Y, Britigan BE, Singh PK (2011) Active starvation responses mediate antibiotic tolerance in biofilms and nutrientlimited bacteria. Science 334(6058):982-986
69. Wakamoto Y, Dhar N, Chait R, Schneider K, Signorino-Gelo F, Leibler S, McKinney JD (2013) Dynamic persistence of antibioticstressed mycobacteria. Science 339(6115): 91-95
70. Amato SM, Orman MA, Brynildsen MP (2013) Metabolic control of persister formation in Escherichia coli. Mol Cell 50(4): 475-487
71. Keren I, Kaldalu N, Spoering A, Wang Y, Lewis K (2004) Persister cells and tolerance to antimicrobials. FEMS Microbiol Lett 230(1): 13-18
72. Fraser D, Kærn M (2009) A chance at survival: gene expression noise and phenotypic diversification strategies. Mol Microbiol 71(6): 1333-1340
73. Möker N, Dean CR, Tao J (2010) Pseudomonas aeruginosa increases formation of multidrug-tolerant persister cells in response to quorum-sensing signaling molecules. J Bacteriol 192(7):1946-1955
74. Leung V, Levesque CM (2012) A stress-inducible quorum-sensing peptide mediates the formation of persister cells with noninherited multidrug tolerance. J Bacteriol 194(9): 2265-2274
75. Gao W, Chua K, Davies JK, Newton HJ, Seemann T, Harrison PF, Holmes NE, Rhee HW, Hong JI, Hartland EL, Stinear TP, Howden BP (2010) Two novel point mutations in clinical Staphylococcus aureus reduce linezolid susceptibility and switch on the stringent response to promote persistent infection. PLoS Pathog 6 (6):e1000944
76. Korch SB, Henderson TA, Hill TM (2003) Characterization of the hipA7 allele of Escherichia coli and evidence that high persistence is governed by (p)ppGpp synthesis. Mol Microbiol 50(4):1199-1213
77. Helaine S, Kugelberg E (2014) Bacterial persisters: formation, eradication, and experimental systems. Trends Microbiol 22(7):417-424
78. Maisonneuve E, Gerdes K (2014) Molecular mechanisms underlying bacterial persisters. Cell 157(3):539-548
79. Amato SM, Fazen CH, Henry TC, Mok WW, Orman MA, Sandvik EL, Volzing KG, Brynildsen MP (2014) The role of metabolism in bacterial persistence. Front Microbiol 5:70
80. Prax M, Bertram R (2014) Metabolic aspects of bacterial persisters. Front Cell Infect Microbiol 4:148
81. Kint CI, Verstraeten N, Fauvart M, Michiels J (2012) New-found fundamentals of bacterial persistence. Trends Microbiol 20(12): 577-585
82. Sharma SV, Lee DY, Li B, Quinlan MP, Takahashi F, Maheswaran S, McDermott U, Azizian N, Zou L, Fischbach MA, Wong KK, Brandstetter K, Wittner B, Ramaswamy S, Classon M, Settleman J (2010) A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. Cell 141(1):69-80
83. Spencer SL, Gaudet S, Albeck JG, Burke JM, Sorger PK (2009) Non-genetic origins of cellto-cell variability in TRAIL-induced apoptosis. Nature 459(7245):428-432
84. Glickman MS, Sawyers CL (2012) Converting cancer therapies into cures: lessons from infectious diseases. Cell 148(6):1089-1098